Telomerase in endocrine and endocrine-dependent tumors

Vasef, 1999, Telomerase activity in human solid tumors, Am. J. Clin. Pathol., 112, 68 Blackburn, 1991, Structure and function of telomeres, Nature, 350, 569, 10.1038/350569a0 Sharma, 1996, Telomeres, telomerase and cancer: is the magic bullet real?, Anticancer Res., 16, 511 Cerni, 2000, Telomeres, telomerase, and myc. An update, Mutation Res., 462, 31, 10.1016/S1383-5742(99)00091-5 Holt, 1999, Role of telomerase in cellular proliferation and cancer, J. Cell Physiol., 180, 10, 10.1002/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D Artandi, 2000, A critical role for telomeres in suppressing and facilitating carcinogenesis, Curr. Opin. Gen. Dev., 10, 39, 10.1016/S0959-437X(99)00047-7 Billaud, 1997, Telomeric localization of TRF2, a novel human telobox protein, Nat. Genet., 17, 236, 10.1038/ng1097-236 van Steensel, 1997, Control of telomere lenght by the human telomeric protein, Nature, 385, 740, 10.1038/385740a0 Smogorzewska, 2000, Control of human telomere lenght by TRF1 and TRF2, Mol. Cell. Biol., 20, 1659, 10.1128/MCB.20.5.1659-1668.2000 Griffith, 1999, Mammalian telomeres and in a large duplex loop, Cell, 97, 503, 10.1016/S0092-8674(00)80760-6 Zakian, 1997, Life and cancer without telomerase, Cell, 91, 1, 10.1016/S0092-8674(01)80001-5 Wright, 1996, Telomerase activity in human germline and embryonic tissues and cell, Dev. Genet., 18, 173, 10.1002/(SICI)1520-6408(1996)18:2<173::AID-DVG10>3.0.CO;2-3 McKenzie, 1999, Applications of telomerase research in the fight against cancer, Mol. Med. Today, 5, 114, 10.1016/S1357-4310(98)01429-4 Holt, 1997, Multiple pathways for the regulation of telomerase activity, Eur. J. Cancer, 33, 761, 10.1016/S0959-8049(97)00066-X Thomas-Wynford, 1999, Cellular senescence and cancer, J. Pathol., 187, 100, 10.1002/(SICI)1096-9896(199901)187:1<100::AID-PATH236>3.0.CO;2-T Dahse, 1997, Telomeres and telomerase: biological and clinical importance, Clin. Chem., 43, 708, 10.1093/clinchem/43.5.708 Collins, 2000, Mammalian telomeres and telomerase, Cur. Opin. Genet. Dev., 12, 378 Blackburn, 1999, The telomere and telomerase: how do they interact?, Mt. Sinai J. Med, 66, 292 Blasco, 1999, Telomeres and telomerase, Genes Dev., 13, 2353, 10.1101/gad.13.18.2353 Hussain, 1999, Bladerunners and telomerases, Eur. J. Endocrinol., 141, 98, 10.1530/eje.0.1410098 Buys, 2000, Telomeres, telomerase and cancer, N. Engl. J. Med., 342, 1282, 10.1056/NEJM200004273421710 Meyerson, 2000, Role of telomerase in normal and cancer cells, J. Clin. Oncol., 18, 2626, 10.1200/JCO.2000.18.13.2626 Dhaene, 2000, Telomeres, telomerase and cancer: an up-date, Virchows Arch., 437, 1, 10.1007/s004280000189 Kim, 1994, Specific association of telomerase activity with immortal cells and cancer, Science, 266, 2011, 10.1126/science.7605428 Hiyama, 1996, Telomerase activity in human breast tumors, J. Natl. Cancer Inst., 88, 116, 10.1093/jnci/88.2.116 Haugen, 1997, Telomerase activity in benign and malignant thyroid tumors, Thyroid, 7, 337, 10.1089/thy.1997.7.337 Kyo, 1997, Application of telomerase assay for the screening of cervical lesions, Cancer Res., 57, 1863 Umbricht, 1997, Telomerase activity: a marker to distinguish follicular thyroid adenoma from carcinoma, Cancer Res., 57, 2144 Kavaler, 1998, Detecting human bladder carcinoma cells in voided urine samples by assaying for the presence of telomerase activity, Cancer, 82, 708, 10.1002/(SICI)1097-0142(19980215)82:4<708::AID-CNCR14>3.0.CO;2-1 Kim, 1997, Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol [TRAP], Nucleic Acid Res., 25, 2595, 10.1093/nar/25.13.2595 Norton, 1998, Enhanced detection of human telomerase activity, DNA Cell Biol., 17, 217, 10.1089/dna.1998.17.217 Gelmini, 1998, Rapid, nonisotopic assay for the quantitation of telomerase activity in human tumor specimens, Clin. Chem., 44, 2133, 10.1093/clinchem/44.10.2133 Mannelli, 2000, Telomerase activity is significantly enhanced in malignant adrenocortical tumors in comparison to benign adrenocortical adenomas, J. Clin. Endocrinol. Metab., 85, 468, 10.1210/jc.85.1.468 Gelmini, 2000, Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay, Clin Cancer Res., 6, 2771 de Kok, 2000, Real-time quantification of human telomerase reverse transcriptase mRNA in tumors and healthy tissues, Clin. Chem., 46, 313, 10.1093/clinchem/46.3.313 Kyo, 1999, Estrogen activates telomerase, Cancer Res., 59, 5917 Misiti, 2000, Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cells, Mol. Cell. Biol., 20, 3764, 10.1128/MCB.20.11.3764-3771.2000 Tanaka, 1998, Expression of telomerase activity in human endometrium is localized to epithelial glandular cells and regulated in a menstrual phase-dependent manner correlated with cell proliferation, Am. J. Pathol., 153, 1985, 10.1016/S0002-9440(10)65712-4 Aldous, 1999, Effects of tamoxifen on telomerase activity in breast carcinoma cell lines, Cancer, 85, 1523, 10.1002/(SICI)1097-0142(19990401)85:7<1523::AID-CNCR13>3.0.CO;2-P Nakayama, 2000, Tamoxifen and gonadal steroids inhibit colon cancer growth in association with inhibition of thymidylate synthase, survivin and telomerase expression through estrogen receptor beta mediated system, Cancer Lett., 161, 63, 10.1016/S0304-3835(00)00600-5 Wang, 2000, Progesterone regulates human telomerase reverse transcriptase gene expression via activation of mitogen-activated protein kinase signaling pathway, Cancer Res., 60, 5376 Soda, 2000, Effects of androgens of telomerase activity in normal and malignant prostate cells in vitro, Prostate, 43, 161, 10.1002/(SICI)1097-0045(20000515)43:3<161::AID-PROS1>3.0.CO;2-O Kiaris, 1999, Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone, Proc. Natl. Acad. Sci. USA, 96, 226, 10.1073/pnas.96.1.226 Hisatake, 1999, 5,6-Trans-16-ene-Vitamin D3: a new class of potent inhibitors of proliferation of prostate, breast, and myeloid leukemic cells, Cancer Res., 59, 4023 Hiyama, 1996, Telomerase activity in human breast tumors, J. Natl. Cancer Inst., 88, 116, 10.1093/jnci/88.2.116 Sugino, 1996, Telomerase activity in human breast cancer and benign breast lesions: diagnostic applications in clinical specimens, including fine needle aspiratesm, Int. J. Cancer, 69, 301, 10.1002/(SICI)1097-0215(19960822)69:4<301::AID-IJC11>3.0.CO;2-8 Landberg, 1997, Telomerase activity is associated with cell cycle deregulation in human breast cancer, Cancer Res., 57, 549 Nawaz, 1997, Telomerase expression in human breast cancer with and without lymph node metastases, Am. J. Clin. Pathol., 107, 542, 10.1093/ajcp/107.5.542 Clark, 1997, Telomerase activity and survival of patients with node-positive breast cancer, J. Natl. Cancer Inst., 89, 1874, 10.1093/jnci/89.24.1874 Hoos, 1998, Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer, Int. J. Cancer, 79, 8, 10.1002/(SICI)1097-0215(19980220)79:1<8::AID-IJC2>3.0.CO;2-5 Pearson, 1998, Detection of telomerase activity in breast masses by fine-needle aspiration, Ann. Surg. Oncol., 5, 186, 10.1007/BF02303853 Villa, 1998, Telomerase activity in benign and malignant breast lesions: a pilot prospective study on fine-needle aspirates, J. Natl. Cancer Inst., 90, 537, 10.1093/jnci/90.7.537 Poremba, 1998, Telomerase activity in human proliferative breast lesions, Int. J. Oncol., 12, 641 Carey, 1998, Carefull histological confirmation and microdissection reveal telomerase activity in otherwise telomerase-negative breast cancers, Clin. Cancer Res., 4, 435 Yashima, 1998, Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma, Clin. Cancer Res., 4, 229 Roos, 1998, Telomerase activity in relation to p53 status and clinico-pathological parameters in breast cancer, Int. J. Cancer, 79, 343, 10.1002/(SICI)1097-0215(19980821)79:4<343::AID-IJC6>3.0.CO;2-V Bednarek, 1997, Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage, Clin. Cancer Res., 3, 11 Tsao, 1997, Telomerase activity in normal and neoplastic breast, Clin. Cancer Res., 3, 627 Mokbel, 1999, Telomerase activity and prognosis in breast cancer, Eur. J. Surg. Oncol., 25, 269, 10.1053/ejso.1998.0640 Umbricht, 1999, Telomerase activity in ductal carcinoma in situ and invasive breast cancer, Oncogene, 18, 3407, 10.1038/sj.onc.1202714 Mokbel, 1999, Telomerase activity in phyllodes tumours, Eur. J. Surg. Oncol., 25, 352, 10.1053/ejso.1999.0656 Mokbel, 1999, The association between telomerase, histopathological parameters, and KI-67 expression in breast cancer, Am. J. Surg., 178, 69, 10.1016/S0002-9610(99)00128-2 Rha, 1999, Changes of telomerase and telomere lengths in paired normal and cancer tissues of breast, Int. J. Oncol., 15, 839 Loveday, 1999, Genetic changes associated with telomerase activity in breast cancer, Int. J. Cancer, 84, 516, 10.1002/(SICI)1097-0215(19991022)84:5<516::AID-IJC12>3.0.CO;2-Y Carey, 1999, Telomerase activity and prognosis in primary breast cancers, J. Clin. Oncol., 17, 3075, 10.1200/JCO.1999.17.10.3075 Poremba, 1999, Telomerase is a highly sensitive and specific molecular marker in fine-needle aspirates of breast lesions, J. Clin. Oncol., 17, 2020, 10.1200/JCO.1999.17.7.2020 Shpitz, 1999, Telomerase activity in ductal carcinoma in situ of the breast, Breast Cancer Res. Treat., 58, 65, 10.1023/A:1006394209922 Mokbel, 2000, Telomerase activity and lymphovascular invasion in breast cancer, Eur. J. Surg. Oncol., 26, 30, 10.1053/ejso.1999.0736 Hiyama, 2000, Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples, Cancer, 25, 235, 10.1002/1097-0142(20000825)90:4<235::AID-CNCR6>3.0.CO;2-Z Zhang, 2000, Frequent amplification of the telomerase reverse transcriptase gene in human tumors, Cancer Res., 60, 6230 Bieche, 2000, Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay, Clin. Cancer Res., 6, 452 Soria, 1999, Molecular detection of telomerase-positive circulating epithelial cells in metastatic breast cancer patients, Clin. Cancer Res., 5, 971 Chen, 2000, Telomerase RNA as a detection marker in the serum of breast cancer patients, Clin. Cancer Res., 6, 3823 Wymenga, 2000, Telomerase activity in needle biopsies from prostate cancer and benign prostates, Eur.. J. Clin. Invest., 30, 330, 10.1046/j.1365-2362.2000.00636.x Wullich, 1999, Focal intratumoral heterogeneity for telomerase activity in human prostate cancer, J. Urol., 161, 1997, 10.1016/S0022-5347(05)68872-6 Engelhardt, 1997, Relative contribution of normal and neoplastic cells determines telomerase activity and telomere length in primary cancers of the prostate, colon, and sarcoma, Clin. Cancer Res., 3, 1849 Koeneman, 1998, Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia [PIN], J. Urol., 160, 1533, 10.1016/S0022-5347(01)62608-9 Lin, 1998, Detection of telomerase activity in prostate needle-biopsy samples, Prostate, 36, 121, 10.1002/(SICI)1097-0045(19980701)36:2<121::AID-PROS7>3.0.CO;2-L Zhang, 1998, Telomerase activity in prostate cancer, prostatic intraepithelial neoplasia, and benign prostatic epithelium, Cancer Res., 58, 619 Takahashi, 1997, Detection of telomerase activity in prostate cancer by needle biopsy, Eur. Urol., 32, 494, 10.1159/000480814 Kallakury, 1997, Telomerase activity in human benign prostate tissue and prostatic adenocarcinomas, Diagn. Mol. Pathol., 6, 192, 10.1097/00019606-199708000-00003 Scates, 1997, Detection of telomerase activity in human prostate: a diagnostic marker for prostatic cancer?, Br. J. Urol., 80, 263, 10.1046/j.1464-410X.1997.00248.x Lin, 1997, Telomerase activity in primary prostate cancer, J. Urol., 157, 1161, 10.1016/S0022-5347(01)65160-7 Sommerfeld, 1996, Telomerase activity: a prevalent marker of malignant human prostate tissue, Cancer Res., 56, 218 Caldarera, 2000, An appraisal of telomerase activity in benign prostatic hyperplasia, Prostate, 45, 267, 10.1002/1097-0045(20001101)45:3<267::AID-PROS10>3.0.CO;2-F Latil, 2000, htert expression correlate with MYC over-expression in human prostate cancer, Int. J. Cancer, 89, 172, 10.1002/(SICI)1097-0215(20000320)89:2<172::AID-IJC12>3.0.CO;2-8 Paradis, 1999, Expression of the RNA component of human telomerase [hTR] in prostate cancer, prostatic intraepithelial neoplasia and normal prostate tissue, J. Pathol., 189, 213, 10.1002/(SICI)1096-9896(199910)189:2<213::AID-PATH417>3.0.CO;2-A Burch, 1995, Evaluation and menagement of the solid thyroid nodule, Endocrinol. Metab. Clin. North Am., 24, 663, 10.1016/S0889-8529(18)30019-7 Gharib, 1993, Fine-needle aspiration of the thyroid: an appraisal, Ann. Intern. Med., 118, 282, 10.7326/0003-4819-118-4-199302150-00007 Brousset, 1997, Telomerase activity in human thyroid carcinomas originating from the follicular cells, J. Clin. Endocrinol. Metab., 82, 4214, 10.1210/jc.82.12.4214 Okayasu, 1997, Significant correlation of telomerase activity in thyroid papillary carcinomas with cell differentiation, proliferation and extrathyroidal extension, Jpn. J. Cancer Res., 88, 965, 10.1111/j.1349-7006.1997.tb00316.x Saji, 1997, Telomerase activity in the differential diagnosis of papillary carcinoma of the thyroid, Surgery, 1221, 1137, 10.1016/S0039-6060(97)90219-1 Yashima, 1997, Telomerase activity in benign and malignant thyroid diseases, Surgery, 122, 1141, 10.1016/S0039-6060(97)90220-8 Cheng, 1998, Telomerase activity in benign and malignant human thyroid tissues, Br. J. Cancer, 77, 2177, 10.1038/bjc.1998.363 Aogi, 1998, Telomerase activity in lesions of the thyroid: application to diagnosis of clinical samples including fine-needle aspirates, Clin. Cancer Res., 4, 1965 De Deken, 1998, Decrease of telomere length in thyroid adenomas without telomerase activity, J. Clin. Endocrinol. Metab., 83, 4368, 10.1210/jc.83.12.4368 Saji, 1999, Human telomerase reverse transcriptase [hTERT] gene expression in thyroid neoplasms, Clin. Cancer Res., 5, 1483 Aogi, 1999, Comparison of telomerase and CD44 expression as diagnostic tumor markers in lesions of the thyroid, Clin. Cancer Res., 5, 2790 Lo, 1999, Telomerase activity in thyroid malignancy, Thyroid, 9, 1215, 10.1089/thy.1999.9.1215 Kammori, 2000, Telomerase activity and telomere length in benign and malignant human thyroid tissues, Cancer Lett., 159, 175, 10.1016/S0304-3835(00)00547-4 Counter, 1995, Telomerase activity in normal leukocytes and in hematological malignancies, Blood, 85, 2315, 10.1182/blood.V85.9.2315.bloodjournal8592315 Hiyama, 1995, Activation of telomerase in human lymphocytes and hematopoietic progenitor cells, J. Immunol., 155, 3711, 10.4049/jimmunol.155.8.3711 Zeiger, 1999, Human telomerase reverse transcriptase [hTERT] gene expression in FNA samples from thyroid neoplasms, Surgery, 126, 1195, 10.1067/msy.2099.101374 Falchetti, 1999, Teleomerase repeat amplification protocol [TRAP]: a new molecular marker for parathyroid carcinoma, Biochem. Biophys. Res. Commun., 265, 252, 10.1006/bbrc.1999.1320 Hirano, 1998, Telomerase activity as an indicator of potentially malignant adrenal tumors, Cancer, 83, 772, 10.1002/(SICI)1097-0142(19980815)83:4<772::AID-CNCR21>3.0.CO;2-O Yano, 1989, Genetic changes in human adrenocortical carcinomas, J. Natl. Cancer Inst., 81, 518, 10.1093/jnci/81.7.518 Kubota, 1998, Elevated levels of telomerase activity in malignant pheochromocytoma, Cancer, 82, 176, 10.1002/(SICI)1097-0142(19980101)82:1<176::AID-CNCR22>3.0.CO;2-Z Kinoshita, 1998, Telomerase activity in adrenal cortical tumors and pheochromocytomas with reference to clinicopathologic features, Urol. Res., 26, 29, 10.1007/s002400050019 Teng, 1998, Telomerase activity in the differentiation of benign and malignant adrenal tumors, Surgery, 124, 1123, 10.1067/msy.1998.92172 Bamberger, 1999, Telomerase activity in benign and malignant adrenal tumors, Exp. Clin. Endocrinol. Diabetes, 107, 272, 10.1055/s-0029-1212111 Cryer, 1985, Pheocromocitoma, Clin. Endocrinol. Metab., 14, 203, 10.1016/S0300-595X(85)80070-0 Evans, 1976, Spontaneous regression of neuroblastoma, Natl. Cancer Inst. Monogr., 44, 49 Evans, 1981, Do infants with stage IV-S neuroblastoma need treatment?, Arch. Dis. Child, 56, 271, 10.1136/adc.56.4.271 Shimada, 1984, Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas, J. Natl. Cancer Inst., 73, 405, 10.1093/jnci/73.2.405 Brodeur, 1984, Amplification of N-myc in untrated human neuroblastomas correlates with advanced diseases stage, Science, 224, 1121, 10.1126/science.6719137 Bourhis, 1991, Combined analysis of DNA ploidy index and N-myc genomic content in neuroblastoma, Cancer Res., 51, 33 Casini Raggi, 2000, Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome, J. Clin. Endocrinol. Metab., 85, 3866, 10.1210/jc.85.10.3866 Hiyama, 1995, Correlating telomerase activity levels with human neuroblastoma outcomes, Nat. Med., 1, 249, 10.1038/nm0395-249 Hiyama, 1997, Telomerase activity in neuroblastoma: is it a prognostic indicator of clinical behaviour?, Eur. J. Cancer, 33, 1932, 10.1016/S0959-8049(97)00226-8 Brinkschmidt, 1998, Comparative genomic hybridization and telomerase activity analysis identify two biologically different groups of 4s neuroblastomas, Br. J. Cancer, 77, 2223, 10.1038/bjc.1998.370 Poremba, 1999, Telomerase activity distinguishes between neuroblastomas with good and poor prognosis, Ann. Oncol., 10, 715, 10.1023/A:1008333500733 Poremba, 2000, Telomerase activity and telomerase subunits gene expression patterns in neuroblastoma: a molecular and immunohistochemical study establishing prognostic tools for fresh-frozen and paraffin-embedded tissues, J. Clin. Oncol., 18, 2582, 10.1200/JCO.2000.18.13.2582 Hiyama, 1999, Rapid detection of MYCN gene amplification and telomerase expression in neuroblastoma, Clin. Cancer Res., 5, 601 Nozaki, 2000, Prognostic impact of telomerase activity in patients with neuroblastoma, Int. J. Oncol., 17, 341 Choi, 2000, Telomerase activity by TRAP assay and telomerase RNA [hTR] expression are predictive of outcome in neuroblastoma, Med. Pediatr. Oncol., 35, 647, 10.1002/1096-911X(20001201)35:6<647::AID-MPO35>3.0.CO;2-I Streutker, 2001, Telomerase activity as a prognostic factor in neuroblastomas, Pediatr. Dev. Pathol., 3, 62, 10.1007/s100240010108 Maitra, 1999, The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors, Cancer, 85, 741, 10.1002/(SICI)1097-0142(19990201)85:3<741::AID-CNCR25>3.0.CO;2-6 Reynolds, 1997, Telomerase expression in primary neuroblastomas, Eur. J. Cancer, 33, 1929, 10.1016/S0959-8049(97)00287-6 Hiyama, 1995, Telomerase activity in small cell and non-small-cell lung cancers, J. Natl. Cancer Inst., 87, 895, 10.1093/jnci/87.12.895 Gomez-Roman, 2000, Telomerase activity in pulmonary neuroendocrine tumors: correlation with histologic subtype [MS-0060], Am. J. Surg. Pathol., 24, 417, 10.1097/00000478-200003000-00011 Yashima, 1997, Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinoma, Cancer Res., 57, 2373 Sarvesvaran, 1999, Is small cell lung carcer the perfect target for anti-telomerase treatment?, Carcinogenesis, 20, 1649, 10.1093/carcin/20.8.1649 Kyo, 1999, Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors, Int. J. Cancer, 80, 804, 10.1002/(SICI)1097-0215(19990315)80:6<804::AID-IJC2>3.0.CO;2-B Selli, 2000, Evidence for elevated telomerase activity in small cell carcinoma of the bladder, Urology, 56, 331, 10.1016/S0090-4295(00)00635-X Lam, 2000, Telomerase activity in pancreatic endocrine tumours: a potential marker for malignancy, Mol. Pathol., 53, 133, 10.1136/mp.53.3.133 Buolamwini, 1999, Novel anticancer drug discovery, Cur. Opin. Chem. Biol., 3, 500, 10.1016/S1367-5931(99)80073-8 Autexier, 1999, Telomerase as a possible target for anticancer therapy, Chem. Biol., 6, 299, 10.1016/S1074-5521(99)80122-7 Burger, 1997, Telomerase activity in normal and malignant mammalian tissues: feasibility of telomerase as a target for cancer chemotherapy, Br. J. Cancer, 75, 516, 10.1038/bjc.1997.90 Newbold, 1999, Telomerase as an anti-cancer drug target: will it fulfil its early promise?, Anticancer Drug Des., 14, 349 Neidle, 1999, Telomerase as an anti-cancer target: current status and future prospects, Anticancer Drug Des., 14, 341 Lichtsteiner, 1999, Telomerase. A target for anticancer therapy, Ann. NY Acad. Sci., 886, 1, 10.1111/j.1749-6632.1999.tb09395.x Greener, 2000, Telomerase: the search for a universal cancer vaccine, Mol. Med. Today, 6, 257, 10.1016/S1357-4310(00)01731-7 Lavelle, 2000, Telomerase: a therapeutic target for the third millennnium?, Crit. Rev. Oncol. Hematol., 34, 111, 10.1016/S1040-8428(00)00057-3 Kondo, 1998, Target therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA, Oncogene, 16, 3323, 10.1038/sj.onc.1201885 Feng, 1995, The RNA component of human telomerase, Science, 269, 1236, 10.1126/science.7544491 Kondo, 1998, Antisense telomerase treatement: induction of two distinct pathways, apoptosis and differentiation, FASEB J., 12, 801, 10.1096/fasebj.12.10.801 Muller, 1998, Telomerase inhibition by induced expression of antisense RNA, Adv. Exp. Med. Biol., 451, 23, 10.1007/978-1-4615-5357-1_4 Bisoffi, 1998, Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA, Eur. J. Cancer, 34, 1242, 10.1016/S0959-8049(98)00049-5 Norton, 1996, Inhibition of human telomerase activity by peptide nucleic acids, Nat. Biotechnol., 14, 615, 10.1038/nbt0596-615 Hamilton, 1999, Cellular delivery of peptide nucleic acids and inhibition of human telomerase, Chem. Biol., 6, 343, 10.1016/S1074-5521(99)80046-5 Hamilton, 1997, Identifications of determinants of inhibitor binding within the RNA active site of human telomerase using PNA scanning, Biochemistry, 36, 11873, 10.1021/bi970438k Yokoyama, 2000, The 5′-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity, Biochem. Biophys. Res. Commun., 273, 316, 10.1006/bbrc.2000.2939 Kanazawa, 1996, Hammerhead ribozyme-mediated inhibition of telomerase activity in extracts of human hepatocellular carcinoma cells, Biochem. Biophys. Res. Commun., 225, 570, 10.1006/bbrc.1996.1213 Yokoyama, 1998, Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells, Cancer Res., 58, 5406 Wan, 1998, Synthetic 2′-O-methyl-modified hammerhead ribozymes targeted to the RNA component of telomerase as sequence-specific inhibitors of telomerase activity, Antisense Nucleic Acid Drug Dev., 8, 309, 10.1089/oli.1.1998.8.309 Strahl, 1996, Effects of reverse transcriptase inhibitors of telomere length and telomerase activity in two immortalized human cell lines, Mol. Cell. Biol., 16, 53, 10.1128/MCB.16.1.53 Gomez, 1998, Irreversible telomere shortening by 3′-azido-2′,3′-dideoxythymidine [AZT] treatement, Biochem. Biophys. Res. Commun., 246, 107, 10.1006/bbrc.1998.8555 Fletcher, 1996, Human telomerase inhibition by 7-deaza-2′-deoxypurine nucleoside triphosphates, Biochemistry, 35, 15611, 10.1021/bi961228v Pai, 1998, Telomerase from human leukemia cells: properties and its interaction with deoxynucleoside analogues, Cancer Res., 58, 1909 Yegorov, 1996, Reverse transcriptase inhibitors suppress telomerase function and induce senescence-like processes in cultured mouse fibroblast, FEBS Lett., 389, 115, 10.1016/0014-5793(96)00533-9 Pandit, 1998, Detection of telomerase in chinese hamster V79 cells and inhibition by 7-deaza-deoxy guanosine triphosphate and [TTAGGG]4 in vitro, Biochem. Biophys. Res. Commun., 251, 620, 10.1006/bbrc.1998.9509 Kerwin, 2000, G-Quadruplex DNA as a target for drug design, Curr. Pharm. Des., 6, 441, 10.2174/1381612003400849 Izbicka, 1999, Effects of cationic porphirins as G-quadruplex interactive agents in human tumor cells, Cancer Res, 59, 639 Wheelhouse, 1998, Cationic porphirins as telomerase inhibitors: the interaction of tera-[N-methyl-4-pyridyl]porphine with quadruplex DNA, J. Am. Chem. Soc., 120, 3261, 10.1021/ja973792e Sun, 1997, Inhibition of human telomerase by a G-quadruplex-interactive compound, J. Med. Chem., 40, 2113, 10.1021/jm970199z Perry, 1998, 1,4- and 2,6-disubstituted amidoanthracene-9,10-dione derivatives as inhibitors of human telomerase, J. Med. Chem., 41, 3253, 10.1021/jm9801105 Fedoroff, 1998, NMR-based model of telomerase-inhibiting compound bound G-quadruplex DNA, Biochemistry, 37, 12367, 10.1021/bi981330n Shay, 1999, Toward identifying a cellular determinant of telomerase repression, J. Natl. Cancer Inst., 91, 4, 10.1093/jnci/91.1.4